NDC properties for "isoflupredone acetate 1 MG / neomycin 3.5 MG (as neomycin sulfate 5 MG) / tetracaine hydrochloride 5 MG per 1 GM Topical Powder" (RxCUI 1551412)
About this data
The tables show NDC propoerties for isoflupredone acetate 1 MG / neomycin 3.5 MG (as neomycin sulfate 5 MG) / tetracaine hydrochloride 5 MG per 1 GM Topical Powder with the RxCUI 1551412
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for isoflupredone acetate 1 MG / neomycin 3.5 MG (as neomycin sulfate 5 MG) / tetracaine hydrochloride 5 MG per 1 GM Topical Powder (RxCUI 1551412)
| RxCUI | 1551412 |
|---|---|
| Prescribable Synonym | isoflupredone acetate 0.001 MG/MG / neomycin 0.0035 MG/MG / tetracaine HCl 0.005 MG/MG Topical Powder |
| RXNAV_STR | isoflupredone acetate 0.001 MG/MG / neomycin 0.0035 MG/MG / tetracaine hydrochloride 0.005 MG/MG Topical Powder |
| RxNorm Name | isoflupredone acetate 0.001 MG/MG / neomycin 0.0035 MG/MG / tetracaine hydrochloride 0.005 MG/MG Topical Powder |
| RxNorm Synonym | isoflupredone acetate 1 MG / neomycin 3.5 MG (as neomycin sulfate 5 MG) / tetracaine hydrochloride 5 MG per 1 GM Topical Powder |
| Related queries | Interactions (for RxCUI 1551412) |
NDC Properties
no results for this query in NIH